With no proven treatment for the coronavirus, and infections in New York topping 30,000, health experts say the Food and Drug Administration has moved with uncommon speed to authorize New York’s sweeping plan to distribute the drugs through hospital networks.Planning for such a complex initiative would ordinarily take up to nine months, those experts say. In New York, the U.S. epicenter of the covid-19 pandemic, that timeline has been compressed into three days.The effort has raised concerns among health experts about safety risks — including the danger of fatal heart arrhythmia and vision loss associated with the drugs — and of raising false hopes in the American public. But Trump’s direct intervention into complex medical issues, as well as New York Gov. Andrew M. Cuomo’s embrace of the strategy, has generated popular excitement about the drugs.The attention by political leaders also has contributed to runs on supply and hoarding, which New York and other states have tried to block with executive orders restricting prescriptions.New York will use three medications — hydroxychloroquine and chloroquine in combination with the antibiotic azithromycin — contributed by the Federal Emergency Management Agency and Amneal Pharmaceuticals, the state said. The first wave of patients will receive


Continue To Full Article